Literature DB >> 12883917

Pathophysiology of tics and Tourette syndrome.

Alfredo Berardelli1, Antonio Currà, Giovanni Fabbrini, Francesca Gilio, Mario Manfredi.   

Abstract

Tics are involuntary movements that can affect one or more muscles producing simple or complex movements. Blink reflex and startle reflex studies disclose an increased excitability of brainstem interneurons. Analysis of voluntary movement shows that when advance visual information is reduced, patients with tics and Tourette syndrome become progressively slower in completing motor sequences. Sensorimotor integration is abnormally processed. Studies of the contingent negative variation demonstrate abnormalities of movement preparation and the investigation of premotor potentials shows that in some patients tics are not preceded by a normal premotor potential. Magnetic stimulation studies demonstrate an increased excitability of cortical motor cortex. Functional MRI, PET and SPECT studies show abnormal activation of cortical and subcortical areas. Dysfunction of basal ganglia-thalamo-cortical projections affects sensorimotor, language and limbic cortical circuits, and may explain why patients with Tourette syndrome have difficulty in inhibiting unwanted behaviors and impulses.

Entities:  

Mesh:

Year:  2003        PMID: 12883917     DOI: 10.1007/s00415-003-1102-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  18 in total

1.  Dopamine receptor modulation of repetitive grooming actions in the rat: potential relevance for Tourette syndrome.

Authors:  Jennifer L Taylor; Abha K Rajbhandari; Kent C Berridge; J Wayne Aldridge
Journal:  Brain Res       Date:  2010-01-28       Impact factor: 3.252

2.  Some stereotypic behaviors in rhesus macaques (Macaca mulatta) are correlated with both perseveration and the ability to cope with acute stressors.

Authors:  Ori Pomerantz; Annika Paukner; Joseph Terkel
Journal:  Behav Brain Res       Date:  2012-02-17       Impact factor: 3.332

Review 3.  Sensory aspects of movement disorders.

Authors:  Neepa Patel; Joseph Jankovic; Mark Hallett
Journal:  Lancet Neurol       Date:  2014-01       Impact factor: 44.182

4.  Randomized Sham Controlled Double-blind Trial of Repetitive Transcranial Magnetic Stimulation for Adults With Severe Tourette Syndrome.

Authors:  Angeli Landeros-Weisenberger; Antonio Mantovani; Maria G Motlagh; Pedro Gomes de Alvarenga; Liliya Katsovich; James F Leckman; Sarah H Lisanby
Journal:  Brain Stimul       Date:  2014-12-03       Impact factor: 8.955

5.  Levetiracetam as an alternative therapy for Tourette syndrome.

Authors:  M A Martínez-Granero; A García-Pérez; F Montañes
Journal:  Neuropsychiatr Dis Treat       Date:  2010-06-24       Impact factor: 2.570

6.  Developmentally regulated and evolutionarily conserved expression of SLITRK1 in brain circuits implicated in Tourette syndrome.

Authors:  Althea A Stillman; Zeljka Krsnik; Jinhao Sun; Mladen-Roko Rasin; Matthew W State; Nenad Sestan; Angeliki Louvi
Journal:  J Comp Neurol       Date:  2009-03-01       Impact factor: 3.215

Review 7.  Tourette's syndrome and role of tetrabenazine: review and personal experience.

Authors:  Mauro Porta; Marco Sassi; Mario Cavallazzi; Maurizio Fornari; Arianna Brambilla; Domenico Servello
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

Review 8.  Deep brain stimulation in Tourette's Syndrome.

Authors:  Linda Ackermans; Yasin Temel; Veerle Visser-Vandewalle
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

Review 9.  Cranial movement disorders: clinical features, pathophysiology, differential diagnosis and treatment.

Authors:  Giovanni Fabbrini; Giovanni Defazio; Carlo Colosimo; Philip D Thompson; Alfredo Berardelli
Journal:  Nat Clin Pract Neurol       Date:  2009-02

10.  Deep brain stimulation of the globus pallidus internus and Gilles de la Tourette syndrome: Toward multiple networks modulation.

Authors:  Christian Saleh; Victoria Gonzalez; Laura Cif; Philippe Coubes
Journal:  Surg Neurol Int       Date:  2012-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.